期刊文献+

抚触联合微生态制剂对新生儿黄疸及行为神经发育的影响 被引量:12

Clinical effect of caresses touches combined with probiotics on neonatal jaundice and behavior nerve growth
在线阅读 下载PDF
导出
摘要 目的探讨抚触联合微生态制剂对新生儿黄疸及行为神经发育的临床疗效。方法选取我院收治的新生儿黄疸150例,按单双数住院号简单随机方法分成两组,对照组70例采用常规治疗方法进行治疗,包括蓝光照射和酶诱导剂等药物治疗;观察组80例在常规治疗的基础上加用抚触联合微生态制剂治疗。观察两组新生儿日均胆红素下降值、黄疸消退时间及行为神经发育情况。结果与对照组比较,观察组新生儿胆红素的日均下降值升高,黄疸消退时间少于对照组(P<0.05),入院后第7天新生儿行为神经评分高于对照组(P<0.05)。结论抚触联合微生态制剂可降低新生儿黄疸指数,促进其行为神经发育,有积极的临床意义。 Objective To explore the clinical effect of caresses touches combined with probiotics on neonatal jaundice behavior nerve growth. Methods One hundred and fifty neonatal jaundice patients were randomly divided into two groups, i.e. trial group and control group. The control group ( n = 70) was treated by conventional treatment, including blue light irradiation and drug ad- ministration, and the trial group ( n = 80) was treated with conventional therapy combined with caresses touches and probiotics. The effects of the two groups were analyzed after treatment. Results There were significant differences in daily bilirubin decrease and jaundice duration period between the two groups (P 〈 0.05 ). Neonatal behavioral neurological assessment (NBNA) grade was obviously higher in the trial group than in the control group after 7 days ( P 〈 0.05 ). Conclusion Caresses touches combined with probioties can reduce the jaundice index and promote the behavior nerve growth of the newborns with hyperbilirubinemia, and it is worth extensively applying in clinical practice.
出处 《临床军医杂志》 CAS 2014年第7期732-733,760,共3页 Clinical Journal of Medical Officers
关键词 抚触 微生态制剂 新生儿黄疸 新生儿行为神经测定 caresses touches probiotics neonatal jaundice neonatal behavioral neurological assessment
  • 相关文献

参考文献7

二级参考文献23

共引文献829

同被引文献150

  • 1李秋平,封志纯.美国儿科学会最新新生儿黄疸诊疗指南[J].实用儿科临床杂志,2006,21(14):958-960. 被引量:160
  • 2沈晓明,王卫平.儿科学[M].第7版.北京:人民卫生出版社,2008:38.
  • 3邱婧,王春梅.应用茵栀黄口服液治疗新生儿黄疸的临床效果评价[J].中国优生优育,2014,20(3):199-200.
  • 4D'Silva S,Colah RB,Ghosh K,et al. Combined effects of the UGT1A1 and OATP2 gene polymorphisms as major risk factor forunconjugated hyperbilirubinemia in Indian neonates [J]. Gene,2014,547( 1 ) : 18-22.
  • 5Cortey A,Elzaabi M,Waegemans T,et al. Efficacy and safety of intravenous immunoglobulins in the management of neonatalhyperbilirubinemia due to ABO incompatibility: a meta-analysis [J]. Arch Pediatr, 2014,21 (9) : 976-983.
  • 6Amin SB,Wang H. Unbound unconjugated hyperbilirubi- nemia is associated with central apnea in premature infants [J]. J Pediatr, 2015,166 ( 3 ) : 571-575.
  • 7Sane RS,Steinmann GG,Huang Q,et al. Mechanisms und- erlying benign and reversible unconjugated hyperbiliru- binemia observed with faldaprevir administration in hep- atitis C virus patients [J]. J Pharmacol Exp Ther,2014,351 (2) :403-412.
  • 8Fallah R, Karimi M, Bafrooee HB. Does moderate uncon- jugated hyperbilirubinemia in healthy term neonates play a rote on their neurodevelopmental status at the age of 18 months? [J]. J Med Liban,2013,61 (3):170-174.
  • 9Tartaglia KM,Campbell J,Shaniuk P,et al. A quality project to improve compliance with AAP guidelines for inpatient management of neonatalhyperbitirubinemia [J]. Hosp Pediatr, 2013,3 (3) : 251-257.
  • 10Maisels MJ, McDonagh AF. Phototherapy for Neonatal Jaundice [J]. N Enql J Meal,2008,358(23):920-928.

引证文献12

二级引证文献216

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部